ArticleScientific reports2025

Selective HDAC6 inhibitor WT161 modulates the VLA-4/FAK pathway by inhibiting PKA activity in acute lymphoblastic leukemia.

Chengfang Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.